Bristol-Myers Squibb Q2 Adjusted EPS $1.75 Misses $1.98 Estimate, Sales $11.23B Miss $11.81B Estimate
Portfolio Pulse from Benzinga Newsdesk
Bristol-Myers Squibb's Q2 earnings per share of $1.75 missed the analyst consensus estimate of $1.98 by 11.62%. This is a 9.33% decrease from the same period last year. The company's quarterly sales of $11.23 billion also missed the analyst consensus estimate of $11.81 billion by 4.94%, marking a 5.56% decrease from the same period last year.
July 27, 2023 | 11:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bristol-Myers Squibb's Q2 earnings and sales missed estimates, marking decreases from the same period last year.
Bristol-Myers Squibb's Q2 earnings and sales missed analyst estimates, which is likely to negatively impact investor sentiment and potentially lead to a decrease in the company's stock price in the short term.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100